LU91024I2
Substituted isoxazoles for the treatment of inflammation
Abstract
A class of substituted isoxazolyl compounds is described for use in treating cyclooxygenase-2 related disorders. Compounds of particular interest are defined by Formula I <IMAGE> I wherein R1, R2, and R3, are described in the specification.
Term
Term ended
Projected expiry passed 4 June 2023, 3.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
55 members in 25 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 38768095 | United States of America | A | |
| 38768095 | United States of America | A | |
| 47388495 | United States of America | A | |
| 47388495 | United States of America | A | |
| 9601869 | United States of America | W | |
| 9601869 | United States of America | W | |
| US19950387680 | – | – | – |
| US19950473884 | – | – | – |
| WO1996US01869 | – | – | – |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| CA2212836A1 | Canada | A1 | |
| WO9625405A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4867196A | Australia | A | |
| ZA961150B | South Africa | B | |
| US5633272A | United States of America | A | |
| NO973711D0 | Norway | D0 | |
| NO973711L | Norway | L | |
| FI973292A | Finland | A | |
| BR9607035A | Brazil | A | |
| EP0809636A1 | European Patent Office (EPO) | A1 | |
| PL321814A1 | Poland | A1 | |
| CZ254697A3 | Czechia | A3 | |
| CN1181075A | China | A | |
| KR19980702181A | Republic of Korea | A | |
| AU699593B2 | Australia | B2 | |
| US5859257A | United States of America | A | |
| JPH11503722A | Japan | A | |
| NZ302586A | New Zealand | A | |
| US5985902A | United States of America | A | |
| NO312066B1 | Norway | B1 | |
| JP3267300B2 | Japan | B2 | |
| JP2002179656A | Japan | A | |
| EP1223167A2 | European Patent Office (EPO) | A2 | |
| EP1223167A3 | European Patent Office (EPO) | A3 | |
| KR100340771B1 | Republic of Korea | B1 | |
| EP0809636B1 | European Patent Office (EPO) | B1 | |
| AT223390T | Austria | T | |
| ATE223390T1 | Austria | T1 | |
| DE69623444D1 | Germany | D1 | |
| PT809636E | Portugal | E | |
| DK0809636T3 | Denmark | T3 | |
| RU2200158C2 | Russian Federation | C2 | |
| ES2183935T3 | Spain | T3 | |
| CN1107058C | China | C | |
| PL185510B1 | Poland | B1 | |
| PL185544B1 | Poland | B1 | |
| DE69623444T2 | Germany | T2 | |
| NL300128I1 | Netherlands (Kingdom of the) | I1 | |
| LU91024I2This record | Luxembourg | I2 | |
| CA2212836C | Canada | C | |
| NL300128I2 | Netherlands (Kingdom of the) | I2 | |
| CN1442139A | China | A | |
| CZ293211B6 | Czechia | B6 | |
| HK1058004A1 | Hong Kong, China | A1 | |
| NZ336369A | New Zealand | A | |
| EP1528059A2 | European Patent Office (EPO) | A2 | |
| EP1528059A3 | European Patent Office (EPO) | A3 | |
| RO119946B1 | Romania | B1 | |
| CN1214790C | China | C | |
| DE10399017I2 | Germany | I2 | |
| NZ536382A | New Zealand | A | |
| NO2003005I2 | Norway | I2 | |
| RO121903B1 | Romania | B1 | |
| FI120736B | Finland | B | |
| DE10399017I1 | Germany | I1 |
Numbers
- Publication, DOCDB
- 91024
- Publication, EPODOC
- LU91024I
- Application
- 91024
- Application, DOCDB
- 91024
- Application, EPODOC
- LU20030091024C
Titles2
- French
- Valdecoxib ou ses sels pharmaceutiquement acceptables
- English
- Valdecoxib or its pharmaceutically acceptable salts
Classification
- CPC, 32
- C07D261/10
- C07D261/08
- C07D261/12
- C07D261/18
- C07D413/04
- A61P1/00
- A61P1/02
- A61P1/04
- A61P11/00
- A61P11/02
- A61P11/06
- A61P13/12
- A61P17/02
- A61P17/06
- A61P19/02
- A61P19/06
- A61P19/08
- A61P21/04
- A61P25/00
- A61P25/04
- A61P25/06
- A61P25/28
- A61P27/02
- A61P29/00
- A61P31/12
- A61P35/00
- A61P37/00
- A61P43/00
- A61P7/00
- A61P7/06
- A61P9/10
- A61P3/10
- IPC, 34
- A61K31 42
- A61K31 4439
- A61P1 00
- A61P1 02
- A61P1 04
- A61P3 10
- A61P7 00
- A61P7 06
- A61P9 10
- A61P11 00
- A61P11 02
- A61P11 06
- A61P13 12
- A61P17 02
- A61P17 06
- A61P19 02
- A61P19 06
- A61P19 08
- A61P21 04
- A61P25 00
- A61P25 04
- A61P25 06
- A61P25 28
- A61P27 02
- A61P29 00
- A61P31 12
- A61P35 00
- A61P37 00
- A61P43 00
- C07D261 08
- C07D261 10
- C07D261 12
- C07D261 18
- C07D413 04